How to keep patients with chronic heart failure out of hospital

2019-05-10

Harriette Van Spall

This lecture was recorded at the 4th McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

0:00

Loaded: 0%

Progress: 0%

Stream TypeLIVE

0:00

See also

Secondary prevention of cardiovascular diseases: current state-of-art A lecture by Dr Gerd Hasenfuß, from the University of Göttingen, Germany, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
What is new in the management of acute coronary syndromes A lecture by Dr Zaza Iakobishvilil, from Rabin Medical Center, Israel, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
How to approach a patient with an overdose of new designer drugs A lecture by Dr Dan Perri, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
How to treat arterial hypertension in elderly people A lecture by Dr Franz H. Messerli, from Icahn School of Medicine at Mount Sinai, USA, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Adjusting exercise in patients with heart failure How to adjust the level of exercise in a patient with heart failure?
New approach to perioperative cardiovascular care: a task for internists A lecture by Dr P.J. Devereaux, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Optimal treatment of heart failure in preserved, reduced, or mid-range LVEF What is the optimal treatment of heart failure in patients with preserved, reduced, or mid-range LVEF? Should patients with mid-range LVEF be treated similarly to those with reduced LVEF?
Heart failure treatment: A decade of progress Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, puts in context some of the most impactful heart failure clinical trials of recent years.
Heart failure treatment: The evolution of vasodilators Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, discusses the evolution of vasodilators used in heart failure treatment.
Heart failure treatment: SGLT-2 inhibitors Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, answers questions about the role of SGLT-2 inhibitors in heart failure treatment.

How to keep patients with chronic heart failure out of hospital

Social Media